The EU's sweeping new rules on the regulation of medicines has been one of the most bitterly contested pieces of legislation ...

America's pharmaceutical sector is facing huge uncertainty from the tariff threat, cuts at the US Department of Health, and a ...

Explore the future of the pharmaceutical industry with this comprehensive report. Delve into key trends via regulatory, clinical, and market analyses. Essential for investors, new entrants, and pharma ...

The purpose of the pharma package is to revise the current rules on medicines to make them more accessible to patients while keeping EU industry competitive.

The Council has agreed its position on new rules that will make the EU’s pharmaceutical sector fairer and more competitive.

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh ...

Discover trends shaping the pharmaceutical sector. Get insights on rising prescription drug prices, supply chains, and growth ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

Less than two weeks after the Senate moved to create a new prescription drug price cap system in Massachusetts, an industry official warned against legislative “leapfrog” that could ...

Indian pharmaceutical industry is known for its generic medicines and low-cost ... sector expects sales to grow 8-10% in the financial year 2023-24, indicated an analysis done by CRISIL, a global ...